GD vs LAB · P/E 22, rev $52.55B vs rev $174.4M
General Dynamics Corporation (GD) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
GD currently screens at market cap $93.69B and trailing P/E 21.8. LAB currently screens at market cap $317.1M.
Not investment advice. Open the GD and LAB stock pages for the full models.
Not investment advice.